Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Particle Accelerators × Clear all

Phase

Status

Completed 3 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioma 1 Glioblastoma 1

Interventions

Cyclophosphamide 353 Carboplatin 300 pembrolizumab 280 Gemcitabine 278 Cisplatin 278 Radiotherapy 265 Paclitaxel 262 Docetaxel 251 Bevacizumab 220 Rituximab 206 Capecitabine 199 Nivolumab 189 Fluorouracil 177 Dexamethasone 176 fludarabine 162 Oxaliplatin 155 Doxorubicin 139 Leucovorin 132 Irinotecan 131 Etoposide 129 Pemetrexed 126 Cytarabine 124 fludarabine phosphate 113 Bortezomib 113 Lenalidomide 109 Filgrastim 109 Cetuximab 109 Erlotinib Hydrochloride 105 Temozolomide 101 Radiation 100

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01700569 2023-02-21

FOLAGLI

Institut Cancerologie de l'Ouest

Phase 1 Terminated

Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡